donepezil patch (BR4002) / Boryung Group - LARVOL DELTA

Yungjin Pharm secures exclusive Korean distribution rights for Celltrion’s Alzheimer’s patch (Korea Biomedical Review) - "Yungjin Pharm said it has signed an agreement to exclusively distribute Celltrion’s Donerion Patch (ingredient: donepezil), the world’s first donepezil patch medication for Alzheimer’s disease, in Korea. Under the accord, Yungjin Pharm has started exclusively distributing and marketing Donerion Patch in Korea since last Wednesday."

Commercial • Alzheimer's Disease

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers (clinicaltrials.gov) - P1; N=18; Completed; Sponsor: Boryung Pharmaceutical Co., Ltd; Recruiting ➔ Completed; Trial completion date: Jan 2021 ➔ Oct 2020

Clinical • Trial completion • Trial completion date • Alzheimer's Disease • CNS Disorders • Dementia

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers (clinicaltrials.gov) - P1; N=18; Recruiting; Sponsor: Boryung Pharmaceutical Co., Ltd

Clinical • New P1 trial • Alzheimer's Disease • CNS Disorders • Dementia